Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Naunyn Schmiedebergs Arch
McArthur Poblacion, Brgy
Abstract Previous studies have explored the effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in reducing cardiovascular events in type 2 diabetes
Minimizing side effects through lower doses can improve tolerability and adherence to treatment plans
Muscle loss is not a pharmacological inevitability, but rather the predictable outcome of aggressive weight loss without adequate protein or progressive overload
Exenatide protects against glucose- and lipid-induced endothelial dysfunction: evidence for direct vasodilation effect of GLP-1 receptor agonists in humans
US$ 24.71
US$ 26.60
US$ 26.77
US$ 19.98
